Profile data is unavailable for this security.
About the company
Encompass Health Corporation is an owner and operator of inpatient rehabilitation hospitals in the United States. The Company provides specialized rehabilitative treatment on an inpatient basis. It operates hospitals in 37 states and Puerto Rico, with concentrations in Florida and Texas. It operates 161 inpatient rehabilitation hospitals. Its inpatient rehabilitation hospitals offer specialized rehabilitative care across an array of diagnoses and deliver comprehensive patient care services. The Company provides care to patients who suffer from cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures and a variety of debilitating neurological conditions. Its hospitals also treat patients with or recovering from the COVID-19 virus. Its hospitals have settings for treating the debilitating effects of the COVID-19 virus, such as significant muscle weakness, cognitive impairments, shortness of breath with activity and malnutrition.
- Revenue in USD (TTM)5.22bn
- Net income in USD431.20m
- Incorporated1984
- Employees22.36k
- LocationEncompass Health Corp9001 Liberty PkwyBIRMINGHAM 35242-7509United StatesUSA
- Phone+1 (205) 967-7116
- Fax+1 (302) 636-5454
- Websitehttps://www.encompasshealth.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Radnet Inc | 1.71bn | 9.92m | 5.36bn | 7.87k | 493.97 | 6.09 | 30.80 | 3.13 | 0.1468 | 0.1468 | 24.52 | 11.91 | 0.5775 | -- | 8.14 | 217,704.80 | 1.43 | 1.24 | 1.83 | 1.66 | 22.82 | 21.56 | 2.48 | 1.86 | -- | 1.52 | 0.4844 | 0.00 | 13.05 | 10.64 | -71.42 | -37.63 | 19.60 | -- |
| R1 Rcm Inc | 2.46bn | -61.20m | 6.03bn | 29.40k | -- | 2.14 | 23.92 | 2.45 | -0.1456 | -0.1456 | 5.74 | 6.66 | 0.4567 | -- | 6.02 | 83,799.32 | -1.13 | 1.35 | -1.22 | 1.53 | 19.19 | 20.09 | -2.48 | 1.96 | -- | 1.24 | 0.4401 | -- | 24.79 | 21.02 | 105.21 | -- | 25.07 | -- |
| CorVel Corp | 845.64m | 81.52m | 6.15bn | 4.87k | 76.30 | 21.75 | 78.56 | 7.27 | 4.70 | 4.70 | 48.80 | 16.51 | 1.78 | -- | 8.93 | 173,642.30 | 17.11 | 14.87 | 29.47 | 24.21 | 21.81 | 22.14 | 9.64 | 9.16 | -- | -- | -- | 0.00 | 10.68 | 5.95 | 14.90 | 10.57 | 13.87 | -- |
| Chemed Corp | 2.38bn | 301.73m | 8.36bn | 15.09k | 28.22 | 6.74 | 22.95 | 3.52 | 19.78 | 19.78 | 155.82 | 82.78 | 1.43 | 136.49 | 13.04 | 157,566.50 | 18.11 | 19.53 | 21.79 | 24.64 | 35.66 | 34.60 | 12.69 | 12.60 | 1.81 | -- | 0.00 | 8.15 | 6.06 | 4.90 | 9.17 | 5.80 | 1.46 | 6.10 |
| Ensign Group Inc | 4.11bn | 239.98m | 8.49bn | 35.30k | 35.86 | 4.86 | 26.41 | 2.07 | 4.13 | 4.13 | 70.86 | 30.50 | 0.9433 | -- | 8.01 | 116,391.30 | 5.52 | 6.45 | 6.63 | 7.88 | 21.19 | 22.32 | 5.85 | 6.48 | -- | -- | 0.0773 | 6.56 | 23.27 | 16.28 | -6.80 | 28.62 | 4.40 | 5.02 |
| Encompass Health Corp | 5.22bn | 431.20m | 10.40bn | 22.36k | 24.43 | 5.31 | 12.16 | 1.99 | 4.23 | 4.11 | 51.10 | 19.45 | 0.8396 | -- | 9.38 | 233,270.70 | 9.07 | 6.37 | 11.87 | 7.94 | 95.49 | 95.58 | 10.80 | 9.16 | -- | 6.14 | 0.486 | 30.78 | 10.41 | 2.34 | 41.31 | 4.49 | 16.60 | -10.42 |
| Davita Inc | 12.67bn | 827.68m | 12.27bn | 70.00k | 16.13 | 31.98 | 6.54 | 0.9689 | 9.28 | 9.28 | 141.50 | 4.68 | 0.7357 | 71.34 | 5.90 | 180,951.60 | 6.58 | 5.62 | 8.88 | 7.45 | 32.80 | 30.70 | 8.94 | 8.33 | 1.33 | 4.77 | 0.8115 | -- | 4.57 | 1.26 | 26.44 | 2.33 | -10.47 | -- |
| Universal Health Services, Inc. | 15.42bn | 1.03bn | 13.70bn | 73.35k | 13.80 | 2.10 | 8.41 | 0.8888 | 15.03 | 15.03 | 225.85 | 99.02 | 1.09 | -- | 6.93 | 210,194.40 | 7.41 | 6.44 | 8.68 | 7.63 | -- | -- | 6.78 | 6.55 | 1.28 | 7.70 | 0.4105 | 6.06 | 6.59 | 5.80 | 6.32 | -1.47 | 1.17 | 14.87 |
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 30 Jun 2024 | 10.10m | 10.03% |
| BlackRock Fund Advisorsas of 30 Jun 2024 | 8.28m | 8.23% |
| Wellington Management Co. LLPas of 30 Sep 2024 | 5.22m | 5.19% |
| Invesco Advisers, Inc.as of 30 Jun 2024 | 4.35m | 4.32% |
| William Blair Investment Management LLCas of 30 Sep 2024 | 3.52m | 3.50% |
| SSgA Funds Management, Inc.as of 30 Jun 2024 | 3.00m | 2.99% |
| Fidelity Management & Research Co. LLCas of 30 Jun 2024 | 1.98m | 1.96% |
| TD Asset Management, Inc.as of 30 Sep 2024 | 1.69m | 1.68% |
| Dimensional Fund Advisors LPas of 30 Sep 2024 | 1.68m | 1.67% |
| Geode Capital Management LLCas of 30 Jun 2024 | 1.65m | 1.64% |
